Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 71326 - 71350 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Silicon dioxide	Approved	KLF6	1316	upregulated	Silicon Dioxide analog results in increased expression of KLF6 mRNA	10p15.2	A24195
Silicon dioxide	Approved	KLF6	1316	upregulated	Silicon Dioxide results in increased expression of KLF6 mRNA	10p15.2	A24196
Silicon dioxide	Approved	KLF8	11279	downregulated	Silicon Dioxide analog results in decreased expression of KLF8 mRNA	Xp11.21	A24195
Silicon dioxide	Approved	KLF9	687	downregulated	Silicon Dioxide analog results in decreased expression of KLF9 mRNA	9q21.12	A24195
Silicon dioxide	Approved	KLHDC2	23588	downregulated	Silicon Dioxide analog results in decreased expression of KLHDC2 mRNA	14q21.3	A24195
Silicon dioxide	Approved	KLHDC7B	113730	upregulated	Silicon Dioxide analog results in increased expression of KLHDC7B mRNA	22q13.33	A24195
Silicon dioxide	Approved	KLHL21	9903	upregulated	Silicon Dioxide analog results in increased expression of KLHL21 mRNA	1p36.31	A24195
Silicon dioxide	Approved	KLHL24	54800	downregulated	Silicon Dioxide analog results in decreased expression of KLHL24 mRNA	3q27.1	A24195
Silicon dioxide	Approved	KLHL35	283212	upregulated	Silicon Dioxide analog results in increased expression of KLHL35 mRNA	11q13.4	A24195
Silicon dioxide	Approved	KLK1	3816	downregulated	Silicon Dioxide analog results in decreased expression of KLK1 mRNA	19q13.33	A24195
Silicon dioxide	Approved	KLRC1	3821	downregulated	Silicon Dioxide analog results in decreased expression of KLRC1 mRNA	12p13	A24194 A24195
Silicon dioxide	Approved	KLRC3	3823	downregulated	Silicon Dioxide analog results in decreased expression of KLRC3 mRNA	12p13.2	A24195
Silicon dioxide	Approved	KLRC4	8302	downregulated	Silicon Dioxide analog results in decreased expression of KLRC4 mRNA	12p13.2	A24195
Silicon dioxide	Approved	KLRD1	3824	downregulated	Silicon Dioxide analog results in decreased expression of KLRD1 mRNA	12p13	A24194
Silicon dioxide	Approved	KLRG1	10219	downregulated	Silicon Dioxide analog results in decreased expression of KLRG1 mRNA	12p13.31	A24195
Silicon dioxide	Approved	KMO	8564	upregulated	Silicon Dioxide results in increased expression of KMO mRNA	1q43	A24196
Silicon dioxide	Approved	KMT2A	4297	downregulated	Silicon Dioxide analog results in decreased expression of KMT2A mRNA	11q23.3	A24194
Silicon dioxide	Approved	KNDC1	85442	downregulated	Silicon Dioxide analog results in decreased expression of KNDC1 mRNA	10q26.3	A24195
Silicon dioxide	Approved	KNG1	3827	downregulated	Silicon Dioxide analog results in decreased expression of KNG1 mRNA	3q27.3	A24195
Silicon dioxide	Approved	KPNA1	3836	upregulated	Silicon Dioxide results in increased expression of KPNA1 mRNA	3q21.1	A24196
Silicon dioxide	Approved	KPNA2	3838	upregulated	Silicon Dioxide results in increased expression of KPNA2 mRNA	17q24.2	A24196
Silicon dioxide	Approved	KRCC1	51315	downregulated	Silicon Dioxide results in decreased expression of KRCC1 mRNA	2p11.2	A24196
Silicon dioxide	Approved	KREMEN1	83999	downregulated	Silicon Dioxide analog results in decreased expression of KREMEN1 mRNA	22q12.1	A24195
Silicon dioxide	Approved	KREMEN2	79412	upregulated	Silicon Dioxide analog results in increased expression of KREMEN2 mRNA	16p13.3	A24194
Silicon dioxide	Approved	KRT15	3866	upregulated	Silicon Dioxide analog results in increased expression of KRT15 mRNA	17q21.2	A24195

Displaying entries 71326 - 71350 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability